Skip to content

PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors

PK Button Vaporization Electrode for Treatment of Bladder Tumors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01567462
Acronym
PK Button
Enrollment
95
Registered
2012-03-30
Start date
2012-09-30
Completion date
2017-03-28
Last updated
2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Keywords

bladder cancer, transurethral resection of bladder tumors

Brief summary

The purpose of this study is to compare the use of two types of equipment during transurethral resection of bladder tumors (TURBT). The two types of surgical devices are: the monopolar loop electrocautery and the PlasmaKinetic (PK) Button Vaporization Electrode. These two devices do the same task but differ in the way they create electric current when removing cancerous tissue. The investigators hope to examine and compare the uses of these two surgical devices to see if any advantages do exist or whether they actually are similar. The goal of the study is to prove similarity in outcomes between the two techniques and analyze the outcomes resulting from each case.

Detailed description

This study will study the medical intervention used when bladder cancer patients present with a new or recurrent bladder tumor. Currently when patients report these tumors, they undergo a standard practice called transurethral resection of the bladder tumor (TURBT) in order to determine the stage of the cancer. This intervention, accomplished by looking through the urethra using an endoscope, is both diagnostic and potentially therapeutic. An adequately performed TURBT will provide the pathologist with enough tissue to provide tumor grade and stage information. Currently, TURBT is done using equipment called monopolar electrocautery which is in the form a 90-degree loop electrode. Although usually safe and sufficient, this technique can create technical challenges because it can be difficult to position the loop electrode in a dynamically changing cylindrical space (the bladder). Specifically, especially with larger bladder tumors, intraoperative bleeding can obscure visualization and result in incomplete tumor resection as well as inadequate sampling of the layers of the bladder needed to establish tumor stage. Furthermore, monopolar current can result in stimulation of a nerve (the obturator nerve) during resection of wall tumors, resulting in violent movement of the leg which can cause a potential bladder tear as well as possible (iliac) vessel injury. Conversely, a technique using bipolar energy, which has been available for many years, has been readily adopted for the surgical treatment of benign prostatic enlargement. The advantages of a bipolar electrical current include the direct return of electrical current to the loop rather than to a grounding pad placed on the patient's skin. This has the theoretical value of limiting the diffusion of electrical current, and therefore heat, to the surrounding tissue. A further refinement on bipolar energy has been the recent introduction of a piece of equipment called the PlasmaKinetic (PK) Button Vaporization electrode, which is currently approved by the Food and Drug Administration (FDA) for this indication. Coupling bipolar energy into the Button electrode would not only harness the benefits of less thermal spread but also would obviate the geometric challenges associated with loop electrodes during resection of bladder tumors. Procedural advantages would potentially include minimal bleeding, good visualization, and a reduction in the occurrence of the obturator reflex and concomitant bladder perforation. This study is a randomized double-arm trial examining the results of both techniques for bladder cancer TURBT procedures with a minimum of 120 patients at Emory. The purpose of this study is to measure the procedural (intraoperative), short term, as clinically indicated (4-6 weeks), and long-term (3 months) outcomes of TURBT using the PK Button when compared to traditional monopolar loop electrocautery. The goal of the study is to prove equivalence in outcomes between the two techniques.

Interventions

DEVICEMonopolar electrocautery loop in Transurethral resection of bladder tumors

Standard monopolar electrocautery loop in transurethral resection of bladder tumors (TURBT)

DEVICEPK Button Vaporization Electrode in transurethral resection of bladder tumors

PlasmaKinetic (PK) Button Vaporization Electrode in transurethral resection of bladder tumors (TURBT)

Sponsors

Olympus
CollaboratorINDUSTRY
Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients with cystoscopically detected bladder tumors requiring TURBT * Patients with bladder tumors which are endoscopically resectable by surgeon's judgment with only one trip into the operating room.

Exclusion criteria

* Patients with clinical evidence of locally advanced, nodal, or metastatic bladder cancer * Patients with hydronephrosis secondary to bladder cancer * Patients with diffuse tumor throughout bladder that is deemed unresectable by surgeon

Design outcomes

Primary

MeasureTime frameDescription
Number of Procedural ComplicationsPost-Intervention (Up to 30 Days)The number of procedural complications describes the total number of post-operative bleeding, need for blood transfusion, bladder perforation, obturator nerve stimulation, catheterization time, or need for hospitalization or bladder irrigation events that occur within thirty days of the procedure.

Secondary

MeasureTime frameDescription
Number of Participants With Disease RecurrencePost-Intervention (Up to 4 Months)The number of participants who had disease recurrence within the four month follow up period.
Mean Catheterization TimeAfter Surgery Completion, Up to 336 HoursThe average duration of the catheterization time was measured through study completion.
Mean Operative TimeAfter Surgery Completion, Up to 174 MinutesThe average operative time was measured through study completion.

Countries

United States

Participant flow

Recruitment details

Participants were recruited between September 2012 and March 2017. Of the 95 participants who signed consent, 90 subjects began study participation.

Participants by arm

ArmCount
Monopolar Loop Electrocautery
Participants completed a transurethral resection of the bladder tumor (TURBT) using monopolar loop electrocautery and all follow up procedures.
41
PK Button Vaporization Electrode
Participants completed a transurethral resection of a bladder tumor using a PK button vaporization electrode and all follow up procedures.
38
Total79

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject47

Baseline characteristics

CharacteristicPK Button Vaporization ElectrodeMonopolar Loop ElectrocauteryTotal
Age, Continuous69.2 years
STANDARD_DEVIATION 11.4
68.7 years
STANDARD_DEVIATION 12.2
69 years
STANDARD_DEVIATION 11.7
Race/Ethnicity, Customized
Non-White
7 Participants7 Participants14 Participants
Race/Ethnicity, Customized
Unreported
9 Participants10 Participants19 Participants
Race/Ethnicity, Customized
White
22 Participants24 Participants46 Participants
Region of Enrollment
United States
38 Participants41 Participants79 Participants
Sex: Female, Male
Female
8 Participants12 Participants20 Participants
Sex: Female, Male
Male
30 Participants29 Participants59 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 450 / 45
other
Total, other adverse events
11 / 454 / 45
serious
Total, serious adverse events
5 / 451 / 45

Outcome results

Primary

Number of Procedural Complications

The number of procedural complications describes the total number of post-operative bleeding, need for blood transfusion, bladder perforation, obturator nerve stimulation, catheterization time, or need for hospitalization or bladder irrigation events that occur within thirty days of the procedure.

Time frame: Post-Intervention (Up to 30 Days)

Population: Participants who completed all study procedures per protocol.

ArmMeasureValue (NUMBER)
Monopolar Loop ElectrocauteryNumber of Procedural Complications23 complications
PK Button Vaporization ElectrodeNumber of Procedural Complications15 complications
Secondary

Mean Catheterization Time

The average duration of the catheterization time was measured through study completion.

Time frame: After Surgery Completion, Up to 336 Hours

Population: Participants who required catheterization after the operative procedure.

ArmMeasureValue (MEAN)Dispersion
Monopolar Loop ElectrocauteryMean Catheterization Time46.7 hoursStandard Deviation 74.9
PK Button Vaporization ElectrodeMean Catheterization Time45.9 hoursStandard Deviation 72.9
Secondary

Mean Operative Time

The average operative time was measured through study completion.

Time frame: After Surgery Completion, Up to 174 Minutes

Population: Participants who completed all study procedures per protocol.

ArmMeasureValue (MEAN)Dispersion
Monopolar Loop ElectrocauteryMean Operative Time46.0 minutesStandard Deviation 28.7
PK Button Vaporization ElectrodeMean Operative Time56.4 minutesStandard Deviation 35.4
Secondary

Number of Participants With Disease Recurrence

The number of participants who had disease recurrence within the four month follow up period.

Time frame: Post-Intervention (Up to 4 Months)

Population: Participants who completed all study procedures per protocol.

ArmMeasureValue (NUMBER)
Monopolar Loop ElectrocauteryNumber of Participants With Disease Recurrence8 participants
PK Button Vaporization ElectrodeNumber of Participants With Disease Recurrence5 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026